TY - JOUR
T1 - Long-term follow-up after near-infrared spectroscopy coronary imaging
T2 - Insights from the lipid cORe plaque association with CLinical events (ORACLE-NIRS) registry
AU - Danek, Barbara Anna
AU - Karatasakis, Aris
AU - Karacsonyi, Judit
AU - Alame, Aya
AU - Resendes, Erica
AU - Kalsaria, Pratik
AU - Nguyen-Trong, Phuong Khanh J
AU - Rangan, Bavana V.
AU - Roesle, Michele
AU - Abdullah, Shuaib
AU - Banerjee, Subhash
AU - Brilakis, Emmanouil S.
PY - 2016/9/3
Y1 - 2016/9/3
N2 - Background: Coronary lipid core plaque may be associated with the incidence of subsequent cardiovascular events. Methods: We analyzed outcomes of 239 patients who underwent near-infrared spectroscopy (NIRS) coronary imaging between 2009-2011. Multivariable Cox regression was used to identify variables independently associated with the incidence of major adverse cardiovascular events (MACE; cardiac mortality, acute coronary syndromes (ACS), stroke, and unplanned revascularization) during follow-up. Results: Mean patient age was 64. ±. 9. years, 99% were men, and 50% were diabetic, presenting with stable coronary artery disease (61%) or an acute coronary syndrome (ACS, 39%). Target vessel pre-stenting median lipid core burden index (LCBI) was 88 [interquartile range, IQR 50-130]. Median LCBI in non-target vessels was 57 [IQR 26-94]. Median follow-up was 5.3. years. The 5-year MACE rate was 37.5% (cardiac mortality was 15.0%). On multivariable analysis the following variables were associated with MACE: diabetes mellitus, prior percutaneous coronary intervention performed at index angiography, and non-target vessel LCBI. Non-target vessel LCBI of 77 was determined using receiver-operating characteristic curve analysis to be a threshold for prediction of MACE in our cohort. The adjusted hazard ratio (HR) for non-target vessel LCBI ≥77 was 14.05 (95% confidence interval (CI) 2.47-133.51, p. =0.002). The 5-year cumulative incidence of events in the above-threshold group was 58.0% vs. 13.1% in the below-threshold group. Conclusion: During long-term follow-up of patients who underwent NIRS imaging, high LCBI in a non-PCI target vessel was associated with increased incidence of MACE.
AB - Background: Coronary lipid core plaque may be associated with the incidence of subsequent cardiovascular events. Methods: We analyzed outcomes of 239 patients who underwent near-infrared spectroscopy (NIRS) coronary imaging between 2009-2011. Multivariable Cox regression was used to identify variables independently associated with the incidence of major adverse cardiovascular events (MACE; cardiac mortality, acute coronary syndromes (ACS), stroke, and unplanned revascularization) during follow-up. Results: Mean patient age was 64. ±. 9. years, 99% were men, and 50% were diabetic, presenting with stable coronary artery disease (61%) or an acute coronary syndrome (ACS, 39%). Target vessel pre-stenting median lipid core burden index (LCBI) was 88 [interquartile range, IQR 50-130]. Median LCBI in non-target vessels was 57 [IQR 26-94]. Median follow-up was 5.3. years. The 5-year MACE rate was 37.5% (cardiac mortality was 15.0%). On multivariable analysis the following variables were associated with MACE: diabetes mellitus, prior percutaneous coronary intervention performed at index angiography, and non-target vessel LCBI. Non-target vessel LCBI of 77 was determined using receiver-operating characteristic curve analysis to be a threshold for prediction of MACE in our cohort. The adjusted hazard ratio (HR) for non-target vessel LCBI ≥77 was 14.05 (95% confidence interval (CI) 2.47-133.51, p. =0.002). The 5-year cumulative incidence of events in the above-threshold group was 58.0% vs. 13.1% in the below-threshold group. Conclusion: During long-term follow-up of patients who underwent NIRS imaging, high LCBI in a non-PCI target vessel was associated with increased incidence of MACE.
KW - Coronary artery disease
KW - Intravascular imaging
KW - Near-infrared spectroscopy
UR - http://www.scopus.com/inward/record.url?scp=85008173480&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85008173480&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2016.12.006
DO - 10.1016/j.carrev.2016.12.006
M3 - Article
C2 - 28017258
AN - SCOPUS:85008173480
SN - 1553-8389
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
ER -